210 related articles for article (PubMed ID: 35277742)
21. Discordance Between Histopathologic Grading and Dual-Tracer PET/CT Findings in Metastatic NETs and Outcome of
Adnan A; Basu S
J Nucl Med Technol; 2022 Sep; 50(3):248-255. PubMed ID: 34876476
[TBL] [Abstract][Full Text] [Related]
22. A prospective head-to-head comparison of
Jiang Y; Liu Q; Wang G; Sui H; Wang R; Wang J; Zhu Z
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4218-4227. PubMed ID: 35657429
[TBL] [Abstract][Full Text] [Related]
23. Somatostatin receptor imaging with [
Zhao L; Pang Y; Wang Y; Chen J; Zhuang Y; Zhang J; Zhao L; Sun L; Wu H; Chen X; Lin Q; Chen H
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1360-1373. PubMed ID: 34665275
[TBL] [Abstract][Full Text] [Related]
24. Comparison of (18F)FDG PET/CT and (68Ga)DOTATATE PET/CT imaging methods in terms of detection of histological subtype and related SUVmax values in patients with pulmonary carcinoid tumors.
Komek H; Can C; Urakçi Z; Kepenek F
Nucl Med Commun; 2019 May; 40(5):517-524. PubMed ID: 30694875
[TBL] [Abstract][Full Text] [Related]
25. Deep learning generation of preclinical positron emission tomography (PET) images from low-count PET with task-based performance assessment.
Dutta K; Laforest R; Luo J; Jha AK; Shoghi KI
Med Phys; 2024 Jun; 51(6):4324-4339. PubMed ID: 38710222
[TBL] [Abstract][Full Text] [Related]
26. Noise reduction with cross-tracer and cross-protocol deep transfer learning for low-dose PET.
Liu H; Wu J; Lu W; Onofrey JA; Liu YH; Liu C
Phys Med Biol; 2020 Sep; 65(18):185006. PubMed ID: 32924973
[TBL] [Abstract][Full Text] [Related]
27. Comparison of (68)Ga-DOTATATE and (18)F-fluorodeoxyglucose PET/CT in the detection of recurrent medullary thyroid carcinoma.
Conry BG; Papathanasiou ND; Prakash V; Kayani I; Caplin M; Mahmood S; Bomanji JB
Eur J Nucl Med Mol Imaging; 2010 Jan; 37(1):49-57. PubMed ID: 19662413
[TBL] [Abstract][Full Text] [Related]
28. Attenuation correction and truncation completion for breast PET/MR imaging using deep learning.
Li X; Johnson JM; Strigel RM; Bancroft LCH; Hurley SA; Estakhraji SIZ; Kumar M; Fowler AM; McMillan AB
Phys Med Biol; 2024 Feb; 69(4):. PubMed ID: 38252969
[No Abstract] [Full Text] [Related]
29. Evaluation of Atlas-Based Attenuation Correction for Integrated PET/MR in Human Brain: Application of a Head Atlas and Comparison to True CT-Based Attenuation Correction.
Sekine T; Buck A; Delso G; Ter Voert EE; Huellner M; Veit-Haibach P; Warnock G
J Nucl Med; 2016 Feb; 57(2):215-20. PubMed ID: 26493207
[TBL] [Abstract][Full Text] [Related]
30. (68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity.
Chang CA; Pattison DA; Tothill RW; Kong G; Akhurst TJ; Hicks RJ; Hofman MS
Cancer Imaging; 2016 Aug; 16(1):22. PubMed ID: 27535829
[TBL] [Abstract][Full Text] [Related]
31. Independent brain
Armanious K; Küstner T; Reimold M; Nikolaou K; La Fougère C; Yang B; Gatidis S
Hell J Nucl Med; 2019; 22(3):179-186. PubMed ID: 31587027
[TBL] [Abstract][Full Text] [Related]
32. Comparison of
Yu HN; Liu L; Chen QS; He Q; Li YS; Wang Y; Gao S
Orthop Surg; 2021 May; 13(3):791-798. PubMed ID: 33709632
[TBL] [Abstract][Full Text] [Related]
33. MR-guided joint reconstruction of activity and attenuation in brain PET-MR.
Mehranian A; Zaidi H; Reader AJ
Neuroimage; 2017 Nov; 162():276-288. PubMed ID: 28918316
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the Impact of 68Ga-DOTATATE and 18F-FDG PET/CT on Clinical Management in Patients with Neuroendocrine Tumors.
Panagiotidis E; Alshammari A; Michopoulou S; Skoura E; Naik K; Maragkoudakis E; Mohmaduvesh M; Al-Harbi M; Belda M; Caplin ME; Toumpanakis C; Bomanji J
J Nucl Med; 2017 Jan; 58(1):91-96. PubMed ID: 27516446
[TBL] [Abstract][Full Text] [Related]
35. Optimized MLAA for quantitative non-TOF PET/MR of the brain.
Benoit D; Ladefoged CN; Rezaei A; Keller SH; Andersen FL; Højgaard L; Hansen AE; Holm S; Nuyts J
Phys Med Biol; 2016 Dec; 61(24):8854-8874. PubMed ID: 27910823
[TBL] [Abstract][Full Text] [Related]
36. Emission-based estimation of lung attenuation coefficients for attenuation correction in time-of-flight PET/MR.
Mehranian A; Zaidi H
Phys Med Biol; 2015 Jun; 60(12):4813-33. PubMed ID: 26047036
[TBL] [Abstract][Full Text] [Related]
37. Deep learning-based attenuation correction in the absence of structural information for whole-body positron emission tomography imaging.
Dong X; Lei Y; Wang T; Higgins K; Liu T; Curran WJ; Mao H; Nye JA; Yang X
Phys Med Biol; 2020 Mar; 65(5):055011. PubMed ID: 31869826
[TBL] [Abstract][Full Text] [Related]
38. Multi-Atlas-Based Attenuation Correction for Brain 18F-FDG PET Imaging Using a Time-of-Flight PET/MR Scanner: Comparison with Clinical Single-Atlas- and CT-Based Attenuation Correction.
Sekine T; Burgos N; Warnock G; Huellner M; Buck A; Ter Voert EE; Cardoso MJ; Hutton BF; Ourselin S; Veit-Haibach P; Delso G
J Nucl Med; 2016 Aug; 57(8):1258-64. PubMed ID: 27013697
[TBL] [Abstract][Full Text] [Related]
39. Joint Reconstruction of Activity and Attenuation in Time-of-Flight PET: A Quantitative Analysis.
Rezaei A; Deroose CM; Vahle T; Boada F; Nuyts J
J Nucl Med; 2018 Oct; 59(10):1630-1635. PubMed ID: 29496982
[TBL] [Abstract][Full Text] [Related]
40. Decentralized collaborative multi-institutional PET attenuation and scatter correction using federated deep learning.
Shiri I; Vafaei Sadr A; Akhavan A; Salimi Y; Sanaat A; Amini M; Razeghi B; Saberi A; Arabi H; Ferdowsi S; Voloshynovskiy S; Gündüz D; Rahmim A; Zaidi H
Eur J Nucl Med Mol Imaging; 2023 Mar; 50(4):1034-1050. PubMed ID: 36508026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
